Atrial septal defect (ASD) means there is a hole in the wall (the septum) that separates the two top chambers of the heart (the right and left atria). Because of this hole, blood can flow from the high-pressure left atrium to the lower-pressure right atrium. This extra flow makes the right side of the heart and the blood vessels in the lungs work harder. Over time, it can lead to rhythm problems, shortness of breath, heart enlargement, and sometimes heart failure if it remains untreated.
An atrial septal defect is a hole in the wall between the heart’s two upper chambers (the atria). In some families, a single gene called NKX2-5—a master switch that guides early heart development—has a change (mutation) that increases the chance of being born with an ASD. People with NKX2-5–related ASD often have electrical problems of the heart’s wiring (for example, a slow heartbeat or heart block) in addition to the hole itself. Over many years, an untreated ASD can enlarge the right side of the heart, trigger irregular heartbeats, and raise pressure in the lungs. The hole is usually closed with a catheter device or surgery if the right heart is enlarged or if symptoms or complications appear. PMC+2JCI+2
Why NKX2-5 matters (genetics and mechanism)
NKX2-5 encodes a transcription factor—a “master instruction” protein that turns other heart-building genes on and off. Mutations in NKX2-5 can disrupt formation of the atrial septum (the wall) and the conduction system (the “wires” that coordinate heartbeats). This explains why some people in the same family have both an ASD and atrioventricular (AV) block or other rhythm problems, while others may have only one of these features. In animal models, reduced NKX2-5 function leads to conduction defects and cardiomyopathy over time, matching what doctors observe in human families. ScienceDirect+1
In some families, an ASD happens because of a change (a mutation) in a heart-development gene called NKX2-5. NKX2-5 is a “master switch” for building the heart before birth. When one copy of this gene doesn’t work properly, the heart’s partitioning and the electrical wiring may not form completely. The most typical pattern is a secundum-type ASD (a hole in the middle of the atrial septum) together with a tendency to atrioventricular (AV) conduction block (slow electrical signals between the atria and ventricles). This condition often runs in families in an autosomal dominant way, which means a parent with the mutation has a 50% chance of passing it on to a child. JCI+1
Doctors treat the hole itself the same way they treat other ASDs—by closing it with a heart catheter device or with surgery when the hole is large or causes strain on the heart. Lifelong rhythm follow-up is important because people with NKX2-5 mutations are more prone to AV block and other heart rhythm problems even after the ASD is closed. PubMed+1
Other names
People and papers may call this condition by several names:
-
“ASD with AV conduction defects” or “ASD-AV block syndrome”
-
“ASD7” (a label used in genetics for “atrial septal defect type 7 with or without atrioventricular conduction defects”; OMIM #108900)
-
“NKX2-5–related congenital heart disease”
-
“Familial ASD due to NKX2-5 mutation”
All of these describe a very similar picture: a familial ASD linked to NKX2-5 and an increased chance of heart block. Orpha+1
Types
1) By the anatomy of the hole
-
Secundum ASD: The most common type seen with NKX2-5 mutations; the hole is in the fossa ovalis (middle of the septum). JCI
-
Less common with NKX2-5: Primarily secundum is reported; other ASD types (primum, sinus venosus, coronary sinus) are usually due to different developmental pathways, but NKX2-5 families can still show varied defects in some reports. dnatesting.uchicago.edu
2) By the electrical system involvement
-
ASD with normal conduction: Some carriers have only an ASD.
-
ASD with first-degree AV block: The PR interval is prolonged on ECG.
-
ASD with progressive AV block: Conduction can slowly worsen to second- or third-degree block, sometimes requiring a pacemaker in adulthood. PubMed+1
3) By inheritance pattern
-
Familial (autosomal dominant): Multiple affected family members across generations.
-
De novo: New mutation in the child, with unaffected parents; still important for future family planning. JCI
Causes
Below are 20 drivers/mechanisms that can lead to ASD in people with NKX2-5–related disease or make the condition appear and vary within a family. Each item is one short idea in plain language:
-
Loss-of-function mutation: One copy of NKX2-5 does not work, so the atrial septum does not close fully. JCI
-
Dominant-negative effect: A faulty protein interferes with the normal one and disturbs heart-building signals. AHA Journals
-
Missense variants in the homeodomain: Changes in the DNA-binding part alter how target heart genes are turned on/off. eLife
-
Truncating (nonsense) variants: Shortened proteins often cause stronger effects and are linked to ASD plus AV block in families. Nature
-
Splice-site variants: The gene’s message is cut and pasted incorrectly, yielding a faulty protein. AHA Journals
-
Regulatory or promoter changes: The gene is made in the wrong amount or at the wrong time during heart formation. eLife
-
Gene–gene interactions (GATA4/TBX5): NKX2-5 partners with other heart “master switches”; if one is weak, the effect is larger. Wikipedia
-
Electrical system vulnerability: NKX2-5 helps build the AV node; mutations raise the risk of AV block later. JCI
-
Variable penetrance: Not every carrier has the same features—some have only ASD, only block, or both. PubMed
-
Modifier genes: Other common variants may shape hole size or rhythm risk in each person. SpringerOpen
-
De novo mutation: A brand-new change arises in the child during conception. JCI
-
Somatic mosaicism: Some cells carry the mutation while others do not, leading to milder or patchy effects. (Mechanism discussed in congenital heart genetics reviews.) PMC
-
Epigenetic influences: How the NKX2-5 gene is switched on/off during development may be altered. eLife
-
Environmental modifiers (e.g., maternal diabetes, certain exposures) can influence how a mutation expresses. (General CHD genetics concept.) PMC
-
Hemodynamic growth feedback: A small prenatal septal gap can persist and enlarge postnatally because of flow. (General ASD physiology informed by guidelines.) PubMed
-
Developmental timing: If NKX2-5 signaling is off early, septation does not complete; later defects may affect conduction more than structure. eLife
-
Population-specific variants: Some rare changes are seen in particular regions or families (e.g., Southeast Asia, Turkey). BioMed Central+1
-
Conduction tissue remodeling with age: Even after ASD closure, scarring and conduction system changes can unmask AV block. heartrhythmcasereports.com
-
Overlap with other CHD: NKX2-5 can also be linked with VSD, Tetralogy of Fallot, or valve anomalies in some families. dnatesting.uchicago.edu
-
Biological pathway disruption: Downstream heart-building networks (e.g., chamber and AV valve formation genes) are mis-regulated. eLife
Common symptoms and signs
Not everyone has all of these. Many children with a small ASD feel well. Symptoms often start with activity or appear later in life:
-
Easy tiring or getting winded when playing or climbing stairs—extra blood flow strains the right heart.
-
Shortness of breath with exertion; sometimes at rest if the hole is large.
-
Frequent chest colds or chest infections in children due to increased lung blood flow.
-
Poor weight gain or slow growth in infants with large shunts.
-
Palpitations (feeling the heart race or skip) from atrial arrhythmias.
-
Bradycardia (slow pulse) or fainting spells if AV block develops. PubMed
-
Heart murmur heard by a clinician and wide, fixed split S2 on listening (classic ASD finding). PubMed
-
Swelling of legs or abdomen later in life if right-sided heart failure occurs.
-
Stroke or TIA from a clot passing across the hole (paradoxical embolus)—uncommon but possible.
-
Blue lips or fingers with exertion (cyanosis) is unusual in simple ASD, but can occur with very high lung pressure late.
-
Exercise intolerance—reduced stamina in sports.
-
Frequent headaches or migraines, which some people with ASDs report.
-
Irregular heartbeat on ECG, including atrial flutter or fibrillation in adults.
-
Dizziness when the heart rhythm is too slow or too fast.
-
No symptoms at all—many ASDs are found by chance during a check-up or family screening, especially in NKX2-5 families. PubMed
Diagnostic tests
Doctors group tests into bedside checks, lab/genetic studies, electrical tests, and imaging. Below each test is a short “why/what it shows.”
A) Physical examination
-
Vital signs and growth check: Looks for normal oxygen level, heart rate, and growth; slow pulse may hint at AV block. PubMed
-
Precordial palpation: A right-ventricular “heave” can suggest right-sided overload from a left-to-right shunt. PubMed
-
Auscultation (listening with a stethoscope): Classic fixed splitting of S2 and a soft systolic murmur over the pulmonary area. PubMed
-
Peripheral exam: Looks for leg swelling, liver enlargement, or neck vein distention in later disease.
-
Family screening exam: Because NKX2-5 disease is often familial, examining relatives can uncover silent ASDs or conduction issues. JCI
B) Manual/bedside tests
-
Pulse oximetry at rest and with walking: Checks oxygen saturation; usually normal in simple ASD but may drop with lung hypertension.
-
Six-minute walk test: Simple measure of exercise tolerance if symptoms are vague.
-
Bedside rhythm check or event recorder patch: Finds intermittent slow or fast rhythms.
-
Valsalva or posture changes during auscultation: Can change the intensity of murmurs and help confirm a flow murmur from ASD.
-
Bubble study at bedside echo lab (saline contrast): Agitated saline shows microbubbles crossing the atrial septum if a defect or patent foramen ovale is present. PubMed
C) Laboratory and pathological tests
-
Genetic testing for NKX2-5 (sequencing ± deletion/duplication): Confirms the diagnosis in the family, guides cascade testing, and informs rhythm surveillance. dnatesting.uchicago.edu
-
Family (cascade) genetic testing: Tests parents, siblings, and children for the known family variant to find silent carriers. JCI
-
BNP/NT-proBNP: A blood marker that rises with heart strain; supportive but not specific.
-
Routine labs (CBC, thyroid, electrolytes): Rule out other causes of breathlessness or rhythm issues.
-
Research or extended panels (when no variant is found): Broader CHD gene panels can look for changes in partners like GATA4 or TBX5. Wikipedia
D) Electrodiagnostic (heart-electrical) tests
-
12-lead ECG: May show first-degree AV block (long PR), right-axis deviation, or right-bundle pattern from right-sided load. In NKX2-5 families, PR prolongation can be an early clue. PubMed
-
Holter monitor (24–48 hours): Detects intermittent AV block, pauses, or atrial arrhythmias. PMC
-
Event monitor/patch (weeks): Captures rare symptoms like near-fainting or palpitations.
-
Signal-averaged ECG or paced testing (specialist use): Looks for subtle conduction disease if suspicion is high.
-
Electrophysiology (EP) study in select cases: Maps conduction and helps decide on pacing or ablation for arrhythmias. heartrhythmcasereports.com
E) Imaging tests
-
Transthoracic echocardiogram (TTE): First-line test; shows the hole, shunt direction, and right-heart size/strain. PubMed
-
Transesophageal echocardiogram (TEE): Closer look if TTE is unclear; helpful before device closure. PubMed
-
Cardiac MRI (CMR): Precise shunt (Qp:Qs) measurement and right-ventricle volumes; useful when images are tricky. PubMed
-
Cardiac CT angiography: Defines anatomy if MRI is not possible or when pulmonary veins need mapping.
-
Chest X-ray: May show enlarged right heart and prominent pulmonary arteries in large shunts. PubMed\
Non-pharmacological treatments (therapies & other measures)
These steps support heart health and safety but do not close the ASD. Closure (catheter or surgery) is the only corrective therapy when indicated.
-
Specialist follow-up in an Adult Congenital Heart Disease (ACHD) center
Purpose: ensure correct timing of ASD closure and surveillance for rhythm or conduction disease.
Mechanism: periodic imaging (echo/MRI) and rhythm monitoring catch right-heart enlargement, pulmonary vascular disease, or AV block early. AHA Journals+1 -
Family screening and genetic counseling
Purpose: identify relatives who might have an ASD or conduction problem before symptoms occur.
Mechanism: pedigree review, echocardiography, ECGs, and targeted NKX2-5 testing when appropriate guide prevention and early care. dnatesting.uchicago.edu -
Rhythm surveillance and device planning
Purpose: detect pauses, atrial flutter/fibrillation, or progressive AV block.
Mechanism: ECG, Holter/event monitors; timely referral for pacemaker if advanced block develops. JACC -
Exercise guidance
Purpose: keep fitness, avoid unsafe exertion if pulmonary hypertension or significant shunt exists.
Mechanism: individualized exercise plan after cardiology evaluation; formal advice changes after ASD closure. American College of Cardiology -
Endocarditis & procedural precautions
Purpose: reduce infection risk and procedural complications.
Mechanism: contemporary guidance does not recommend routine antibiotic prophylaxis for isolated unrepaired/closed ASD without other risks, but clinicians individualize around device closure and other factors. AHA Journals -
Pregnancy planning
Purpose: plan safe pregnancy timing and follow-up.
Mechanism: pre-pregnancy ACHD consult; most repaired ASDs do well, but unrepaired significant shunts or pulmonary hypertension increase risk. AHA Journals -
Pulmonary hypertension (PH) assessment when indicated
Purpose: avoid harmful closure if pulmonary vascular resistance is too high.
Mechanism: right-heart catheterization and vasoreactivity testing guide therapy and candidacy for closure. American College of Cardiology+1 -
Lifestyle cardio-prevention
Purpose: reduce acquired cardiac risks that can compound congenital issues.
Mechanism: treat blood pressure, diabetes, sleep apnea; tobacco cessation; weight, diet, and activity counseling. (General preventive framing consistent with guideline care pathways.) American College of Cardiology
If you’d like, I can continue with additional supportive measures (cardiac rehab after closure, travel/altitude precautions, vaccination planning in PH, mental-health support for chronic disease, etc.).
Drug treatments
Medicines do not repair the ASD. They are used to control symptoms or treat complications (heart rhythm problems, fluid overload, or pulmonary hypertension). Doses below are typical adult ranges—the exact drug, dose, and timing must be individualized by your cardiology team.
1) Diuretics (e.g., furosemide 20–80 mg PO once–twice daily)
Purpose: relieve fluid retention if right-sided volume overload causes swelling or breathlessness pre-closure.
Mechanism: increase urine output to lower venous pressure; symptom control only.
Side effects: low potassium, kidney issues, dizziness. American College of Cardiology
2) Rate-control beta-blockers (e.g., metoprolol 25–200 mg/day PO divided)
Purpose: slow the heart in atrial arrhythmias or symptomatic palpitations.
Mechanism: block adrenergic drive at the AV node and myocardium.
Side effects: fatigue, low blood pressure, bradycardia. American College of Cardiology
3) Antiarrhythmic agents (e.g., flecainide 50–150 mg BID; amiodarone loading then 100–200 mg/day)
Purpose: maintain normal rhythm in recurrent atrial flutter/fibrillation when appropriate.
Mechanism: sodium-channel blockade (flecainide) or multi-channel/anti-adrenergic effects (amiodarone).
Side effects: pro-arrhythmia (flecainide), thyroid/liver/lung toxicity (amiodarone). Requires specialist oversight. American College of Cardiology
4) Anticoagulation (e.g., apixaban 5 mg BID or warfarin adjusted to INR 2–3 in AF)
Purpose: reduce stroke risk in atrial fibrillation/flutter per standard risk scoring.
Mechanism: inhibits clotting pathways.
Side effects: bleeding; drug interactions. American College of Cardiology
5) ACE inhibitors/ARBs (e.g., enalapril 2.5–20 mg/day)
Purpose: treat ventricular dysfunction if present; blood-pressure control.
Mechanism: reduce afterload and neurohormonal activation.
Side effects: cough (ACEi), high potassium, kidney effects. American College of Cardiology
6) SGLT2 inhibitors (e.g., dapagliflozin 10 mg daily) in heart failure with reduced EF
Purpose: guideline-directed medical therapy (GDMT) if systolic dysfunction co-exists.
Mechanism: natriuresis and metabolic effects that lower HF events.
Side effects: genital infections, volume depletion. (Applied when HF is present; not ASD-specific.) American College of Cardiology
7) Pulmonary vasodilators for Eisenmenger physiology (specialist use)
Examples: endothelin-receptor antagonists (bosentan 62.5 mg BID → 125 mg BID), phosphodiesterase-5 inhibitors (sildenafil 20 mg TID), or prostacyclin-pathway agents.
Purpose: improve exercise capacity and symptoms in selected patients with advanced pulmonary vascular disease.
Mechanism: vasodilation and antiproliferative effects in lung vessels.
Side effects: liver enzyme elevation (bosentan), headaches/flushing (sildenafil), infusion-site issues (prostacyclins). American College of Cardiology
8) Temporary chronotropic agents (e.g., isoproterenol in monitored settings)
Purpose: bridge for symptomatic bradycardia until a pacemaker is placed if AV block is advanced.
Mechanism: beta-agonist to increase heart rate.
Side effects: palpitations, arrhythmias; short-term only. (Definitive therapy for high-grade block is device implantation, not chronic drugs.) JACC
(Additional classes—mineralocorticoid receptor antagonists, loop-thiazide combinations, anticoagulation peri-device closure—are used selectively per guideline-directed pathways.) American College of Cardiology
Dietary molecular supplements
No vitamin or supplement has been proven to treat or close an ASD or reverse NKX2-5–related changes. Supplements below are general heart-health supports used in broader cardiology contexts; discuss each with your clinician to avoid interactions (especially if anticoagulated or on antiarrhythmics).
-
Prenatal folic acid (400–800 µg/day for people who may conceive) – reduces risk of certain congenital defects overall; part of pre-pregnancy planning and public-health guidance. Not a treatment for existing ASD. American College of Cardiology
-
Omega-3 fatty acids (EPA/DHA 1 g/day food-first) – general cardiovascular benefits in selected populations; avoid high doses with anticoagulants unless supervised. American College of Cardiology
-
Vitamin D (per deficiency correction) – bone and general health; no ASD-specific effect. American College of Cardiology
-
Magnesium (dietary intake; supplements only if low) – may help reduce ectopy in deficiency; excess can worsen bradycardia. American College of Cardiology
-
CoQ10 (100–200 mg/day trial basis) – sometimes tried for HF symptom support; evidence variable; not ASD therapy. American College of Cardiology
Because robust, ASD-specific supplement evidence is lacking, your cardiologist may recommend food-first strategies instead of pills.
Immunity booster / regenerative / stem-cell drugs
There are no approved “immunity booster,” regenerative, or stem-cell drugs that treat or reverse NKX2-5–related ASD. Experimental cell-based or gene-based approaches remain at the research stage; outside of a clinical trial they are not recommended. The proven corrective therapy is device or surgical closure when indicated. American College of Cardiology
Procedures and surgeries
-
Transcatheter device closure (for suitable secundum ASDs)
Procedure: a catheter is threaded from a leg vein to the heart; a metal “umbrella” device is deployed across the hole and released.
Why it’s done: preferred minimally invasive option when anatomy is favorable and the right heart is enlarged or symptoms/complications exist per guidelines. PubMed -
Surgical patch closure (for unsuitable anatomy or very large defects)
Procedure: open-heart surgery; the surgeon sutures a patch (often pericardium or synthetic) across the defect.
Why it’s done: for rims too small, multiple holes, or device-unsuitable shapes; excellent long-term outcomes when done at experienced centers. American College of Cardiology -
Concomitant arrhythmia surgery (e.g., maze) when indicated
Procedure: during open repair, surgical lines or ablation patterns reduce atrial fibrillation flutters.
Why it’s done: to address established atrial arrhythmias during the same operation. American College of Cardiology -
Pacemaker implantation (if high-grade AV block develops)
Procedure: leads are placed in the heart and connected to a generator under the skin.
Why it’s done: to prevent slow or dropped heartbeats that can cause fainting or heart failure in NKX2-5–related conduction disease. JACC -
Right-heart catheterization (diagnostic, sometimes therapeutic planning)
Procedure: a small catheter measures lung pressures and shunt size; may include testing response to vasodilators.
Why it’s done: to decide if and how an ASD should be closed, especially when pulmonary hypertension is suspected. American College of Cardiology
Prevention & risk reduction
-
Family screening for ASD/rhythm disease when NKX2-5 mutation is present. dnatesting.uchicago.edu
-
Pre-pregnancy counseling and optimized timing of closure before conception when indicated. AHA Journals
-
Avoid smoking and secondhand smoke; protect lung health. American College of Cardiology
-
Vaccinations and infection prevention, especially if pulmonary hypertension or heart failure develop. American College of Cardiology
-
Heart-healthy diet (vegetables, fruits, whole grains, legumes, lean proteins). American College of Cardiology
-
Regular, safe exercise tailored by your ACHD team. American College of Cardiology
-
Manage blood pressure, diabetes, and sleep apnea. American College of Cardiology
-
Medication review before starting over-the-counter stimulants or decongestants (they can trigger arrhythmias). American College of Cardiology
-
Follow-up after device closure to confirm the device is stable and no residual shunt. PubMed
-
Lifelong cardiology care in an ACHD program. AHA Journals
When to see a doctor (red flags)
-
New or worsening shortness of breath, swelling, fatigue, or exercise intolerance.
-
Palpitations, dizziness, fainting, or very slow/irregular pulse (possible conduction disease).
-
Blue or gray skin color, clubbing, or signs of lung-pressure problems.
-
Pregnancy planning or a positive pregnancy test if you have an unrepaired ASD.
These symptoms warrant prompt ACHD evaluation because timely closure or rhythm management prevents long-term damage. AHA Journals
What to eat (and what to avoid)
Eat more: vegetables, fruits, whole grains, beans, nuts, seeds, fish, and modest unsalted dairy; cook with small amounts of healthy oils. This pattern supports blood pressure, weight, and overall heart function. Limit: excess salt, ultra-processed snacks, sugar-sweetened drinks, and alcohol (especially if on anticoagulants or antiarrhythmics). Avoid stimulant supplements/energy drinks that can provoke palpitations. Food-first strategies beat pills; there is no special ASD diet beyond general heart-healthy eating. American College of Cardiology
Frequently asked questions
-
Can medicines close an ASD? No. Medicines control symptoms or complications; closure is mechanical (device or surgery). PubMed
-
Does everyone with an ASD need closure? No. Closure is advised when the right heart is enlarged or the shunt is significant and lung resistance is acceptable. AHA Journals+1
-
What makes NKX2-5 ASDs different? Added risk of conduction disease and arrhythmias; closer rhythm surveillance is needed. dnatesting.uchicago.edu+1
-
Is catheter closure safe? In suitable anatomy, it’s the preferred option with excellent outcomes in experienced centers. PubMed
-
What if I already have pulmonary hypertension? Specialized testing guides therapy; some patients are not candidates for closure. American College of Cardiology+1
-
Will I need a pacemaker? Only if you develop significant AV block or symptomatic bradycardia. JACC
-
Can I exercise? Usually yes, with a plan tailored by your ACHD team, and adjusted before/after closure. American College of Cardiology
-
Do I need antibiotics before dental work? Not routinely for an isolated ASD; your doctor will individualize advice around device closure timing. AHA Journals
-
Is pregnancy safe after ASD closure? Often yes, with ACHD planning and follow-up. AHA Journals
-
Should my children be checked? Yes—family screening is reasonable in NKX2-5–related disease. dnatesting.uchicago.edu
-
Are “stem-cell” or “regenerative” drugs available? No approved therapies exist; avoid non-trial offerings. American College of Cardiology
-
What is the long-term outlook after closure? Generally excellent when repaired at the right time with ongoing follow-up. American College of Cardiology
-
Can ASD recur after device closure? Rarely; follow-up imaging checks for residual shunt or device issues. PubMed
-
What if I feel fine—do I still need follow-up? Yes; NKX2-5–related conduction disease can appear later in life. JACC
-
Where should I get care? At a center with Adult Congenital Heart Disease expertise. AHA Journals
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: September 25, 2025.
